ClinicalTrials.gg
RecruitingNCT02253290Updated Jul 3, 2024

Neuropsychological and Psychosocial Follow up of Children and Adolescents With Neuromuscular Disease

An observational study in Neuromuscular Diseases, sponsored by Universitaire Ziekenhuizen KU Leuven. Recruiting at 1 site in Belgium. Open to participants aged Up to 18 Years. Per ClinicalTrials.gov, last updated 2024-07-03.

Sponsored by Universitaire Ziekenhuizen KU Leuven · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Apr 2025, 1 year 7 months ago, but the record still lists the study as recruiting.
  • Started Dec 2014; still recruiting 11 years 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Other
Enrollment
300
Ages
Up to 18 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 23 studies in Neuromuscular Diseases with a site in Belgium — 7 open to participants now, 11 under way, 3 of them phase 3. Neuromuscular Diseases · Belgium.

Started
2014
with 2 others
Observational
3 of 23
1 open now
Primary completion
2025-04
later than 3 of 10 live
Registered
7th of 23
by date
Lead sponsor
3 of 23
Universitaire Ziekenhuizen KU Leuven

Among the 23 studies in Neuromuscular Diseases with a site in Belgium, this one is one of 3 that started in 2014, is one of 3 observational ones, reaches primary completion later than 3 of the 10 other live ones, and was the 7th registered.

Neuromuscular Diseases

361 studies on the registry are indexed under Neuromuscular Diseases; 96 are open to participants now.

Browse Neuromuscular Diseases studies →

Open to participants now

7 of the 23 studies in Neuromuscular Diseases with a site in Belgium are open now. Recruiting first, the newest first:

1 more — sign in →

All 7 open studies →

A study can be open while its sites in Belgium have not opened yet or have stopped. Only those recruiting at a site in Belgium →

Who these studies take

Of the 69 Neuromuscular Diseases studies recruiting now, 39 (57%) set no upper age limit and 22 (32%) stop at 75 or younger; 35 take children under 18; 16 take healthy volunteers.

This study: Up to 18 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 23 studies in Neuromuscular Diseases with a site in Belgium, or all of them as a file.
02

Study summary

This project is a retrospective and prospective investigation of neuropsychological and psychosocial development of children with a neuromuscular disease.

Read the detailed description

This project is a retrospective and prospective investigation of neuropsychological and psychosocial development of children with a neuromuscular disease. Children and adolescents in UZ Leuven will be evaluated according to a psychosocial and neuropsychological protocol including different psychological tests and patient questionaires.

03

Conditions studied

  • Neuromuscular Diseases
04

Who can participate

Ages eligible
Up to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

children and adolescents with neuromuscular disease

Eligibility criteria

Inclusion criteria

  • children and adolescents (0-18 years)
  • diagnosis of neuromuscular disease
05

Study design

Observational model
Cohort
Time perspective
Other
Enrollment
300 participants (estimated)
Target follow-up
18 Years
Patient registry
Yes

Groups and cohorts

  • Neuromuscular disease

    Children and adolescents with Neuromuscular disease children according to neuromuscular convention UZL

06

What researchers measure

Primary outcomes

  1. Neuropsychological profile (questionnaires, neuropsychological testing) of children with myotonic dystonia type 1

    Compare the outcome of the questionnaires, IQ test and other neuropsychological test to a normal population

    Time frame: one year

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2014 (actual). Primary completion is estimated for Apr 2025, 124 months after the start.

Of 64 non-industry observational studies under Neuromuscular Diseases, half reached primary completion within 38 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 114. This study's planned 124 months is above that.

Counting every sponsor, half of 70 studies reached it within 37 months; a quarter within 12 and three quarters within 114.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 18, 2014
First posted
Oct 1, 2014
StartActual
Dec 2014
Primary completionEst.
Apr 2025
CompletionEst.
Apr 2025
Last update
Jul 3, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 3, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02253290
Responsible party
Sponsor
First posted
Oct 1, 2014
Start date
Dec 2014
Primary completion
Apr 2025 (estimated)
Completion
Apr 2025 (estimated)
Last update
Jul 3, 2024

Study contacts

Sam Geuens, Master
Contact
sam.geuens@uzleuven.be
+32 16 34 19 91
Nathalie Goemans, MD, PhD
principal investigator · UZ Leuven
Liesbeth De Waele, MD, PhD
principal investigator · UZ Leuven

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion